Journal of Clinical Apheresis · 2018 · 30 citations · 16 references
PharmacyPharmacoeconomicsPharmacotherapyCost-benefit AnalysisCost-effectiveness AnalysisCost-minimization AnalysisEconomic EvaluationHealth Care CostsHealthcare Cost AnalysisIndirect CostsPerspective In Economic EvaluationPharmacoeconomic EvaluationCost-effectiveness Of TherapyDisease Cost Of IllnessHealth Outcome AssessmentMethods Of Economic EvaluationPharmaceutical Cost AnalysisSocietal Perspective AnalysisTherapeutic Plasma ExchangeTreatment Cost Analysis
BACKGROUND: Therapeutic Plasma Exchange (TPE) and Intravenous Immunoglobulin both are first-line treatments for Guillain Barre Syndrome; however, there is a significant difference in cost. We undertook this study to assess the cost minimization for treating Guillain Barre Syndrome patients. METHODS: A prospective randomized controlled trial was undertaken, in which 40 Guillain Barre Syndrome (GBS) patients with a GBS disability score of grade four and five were enrolled. A societal perspective was adopted for the analysis and assessment of both the health system cost and out-of-pocket expenditures. Cost-minimization analysis was undertaken as both the treatments were equally effective at the end of 12 weeks. RESULTS: No statistically significant differences were observed in the GBS Disability scores during overall treatment course in both treatment groups. The Out-of-pocket cost for the immunoglobulin (IVIG) group was INR 219 247 (4298 USD) and for the TPE group was INR 104 070 (2040.5 USD). Overall INR 86 685 ($1700), that is, 53% higher cost was observed in IVIG group without any concomitant health outcome benefit. CONCLUSION: In comparison with IVIG, TPE appears to be the better option for treatment of GBS in cost-constraint countries like ours to provide an economic treatment option to most average people.
16
CONTROLLED TRIAL OF PREDNISOLONE IN ACUTE POLYNEUROPATHY
Richard AC Hughes, John Newsom–Davis, G D Perkin et al. · The Lancet · 1978 · 1.1K citations
Anticipating Mechanical Ventilation in Guillain-Barré Syndrome
Nicholas Lawn, Dade D. Fletcher, Robert D. Henderson et al. · Archives of Neurology · 2001 · 355 citations